Sunovion Pharmaceuticals Inc. formerly known as Sepracor, Inc. announced its new name this week. The name change and updated branding follows Sepracor’s acquisition by Dainippon Sumitomo Pharma Co., Ltd last year.
“This is an exciting time for Sunovion Pharmaceuticals Inc. and we are poised to deliver on our vision to become a leading global pharmaceutical company known for scientifically-advanced products that improve the lives of patients,” said Mark Iwicki, President and Chief Operating Officer of Sunovion. “The meaning of Sunovion combines the strength of the sun with innovation and, for us, represents the start of a great new company. Launching our new corporate identity is a meaningful next step for our employees and partners who have contributed to our past success. We remain focused on our goal to grow our current brands and advance our pipeline candidates.”
Sunovion will continue its sales and marketing efforts offering brands including ALVESCO®, BROVANA®, OMNARIS®, XOPENEX®, XOPENEX HFA®.
We at Word on Health applaud Sunovion’s continued dedication to improving patients’ respiratory health.
SRxA's Word on Health 